NASDAQ:VIVO - Meridian Bioscience News Headlines

$9.99
+0.12 (+1.22 %)
(As of 09/16/2019 04:00 PM ET)
Today's Range
$9.84
Now: $9.99
$10.0150
50-Day Range
$9.13
MA: $10.19
$12.08
52-Week Range
$8.96
Now: $9.99
$19.84
Volume170,030 shs
Average Volume343,836 shs
Market Capitalization$426.68 million
P/E Ratio13.50
Dividend Yield2.53%
Beta0.4

Headlines

Meridian Bioscience (NASDAQ VIVO) News Headlines

Source:
DateHeadline
Head-To-Head Contrast: Heska (NASDAQ:HSKA) versus Meridian Bioscience (NASDAQ:VIVO)Head-To-Head Contrast: Heska (NASDAQ:HSKA) versus Meridian Bioscience (NASDAQ:VIVO)
www.americanbankingnews.com - September 2 at 6:12 AM
Meridian Bioscience, Inc. (NASDAQ:VIVO) Receives Average Recommendation of "Sell" from AnalystsMeridian Bioscience, Inc. (NASDAQ:VIVO) Receives Average Recommendation of "Sell" from Analysts
www.americanbankingnews.com - August 31 at 6:29 AM
Meridian Bioscience, Inc. (NASDAQ:VIVO) Expected to Post Quarterly Sales of $50.33 MillionMeridian Bioscience, Inc. (NASDAQ:VIVO) Expected to Post Quarterly Sales of $50.33 Million
www.americanbankingnews.com - August 30 at 2:25 AM
$0.09 Earnings Per Share Expected for Meridian Bioscience, Inc. (NASDAQ:VIVO) This Quarter$0.09 Earnings Per Share Expected for Meridian Bioscience, Inc. (NASDAQ:VIVO) This Quarter
www.americanbankingnews.com - August 28 at 4:19 PM
Boasting A 14% Return On Equity, Is Meridian Bioscience, Inc. (NASDAQ:VIVO) A Top Quality Stock?Boasting A 14% Return On Equity, Is Meridian Bioscience, Inc. (NASDAQ:VIVO) A Top Quality Stock?
finance.yahoo.com - August 28 at 9:42 AM
Should Value Investors Pick Meridian Bioscience (VIVO) Now?Should Value Investors Pick Meridian Bioscience (VIVO) Now?
finance.yahoo.com - August 24 at 6:18 AM
Edited Transcript of VIVO earnings conference call or presentation 30-Jul-19 2:00pm GMTEdited Transcript of VIVO earnings conference call or presentation 30-Jul-19 2:00pm GMT
finance.yahoo.com - August 1 at 12:26 AM
Meridian Bioscience (VIVO) Beats Q3 Earnings EstimatesMeridian Bioscience (VIVO) Beats Q3 Earnings Estimates
finance.yahoo.com - July 30 at 11:41 PM
Meridian Bioscience Inc (VIVO) Q3 2019 Earnings Call TranscriptMeridian Bioscience Inc (VIVO) Q3 2019 Earnings Call Transcript
finance.yahoo.com - July 30 at 11:41 PM
Meridian Bioscience EPS beats by $0.07, misses on revenueMeridian Bioscience EPS beats by $0.07, misses on revenue
seekingalpha.com - July 30 at 8:22 AM
Meridian Bioscience Reports Third Quarter 2019 Operating ResultsMeridian Bioscience Reports Third Quarter 2019 Operating Results
finance.yahoo.com - July 30 at 8:22 AM
Meridian Bioscience to Hold Third Quarter 2019 Financial Results Conference Call on July 30, 2019Meridian Bioscience to Hold Third Quarter 2019 Financial Results Conference Call on July 30, 2019
finance.yahoo.com - July 10 at 7:08 PM
InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of DirectorsInMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
finance.yahoo.com - July 2 at 8:07 AM
Meridian Bioscience (VIVO) Presents At William Blair Growth Stock Conference - SlideshowMeridian Bioscience (VIVO) Presents At William Blair Growth Stock Conference - Slideshow
seekingalpha.com - June 7 at 8:13 AM
One of Cincinnati’s largest public company’s closes on $50M acquisitionOne of Cincinnati’s largest public company’s closes on $50M acquisition
finance.yahoo.com - June 4 at 7:00 PM
Meridian Bioscience Announces Closing of Transaction to Acquire Business of GenePOCMeridian Bioscience Announces Closing of Transaction to Acquire Business of GenePOC
finance.yahoo.com - June 3 at 7:05 PM
Meridian Bioscience, Inc. (NASDAQ:VIVO) Earns Among The Best Returns In Its IndustryMeridian Bioscience, Inc. (NASDAQ:VIVO) Earns Among The Best Returns In Its Industry
finance.yahoo.com - May 21 at 5:01 AM
Here’s What Hedge Funds Think About Meridian Bioscience, Inc. (VIVO)Here’s What Hedge Funds Think About Meridian Bioscience, Inc. (VIVO)
finance.yahoo.com - May 10 at 8:06 AM
Meridian Bioscience suspends quarterly cash dividendMeridian Bioscience suspends quarterly cash dividend
seekingalpha.com - May 1 at 7:40 PM
Edited Transcript of VIVO earnings conference call or presentation 30-Apr-19 2:00pm GMTEdited Transcript of VIVO earnings conference call or presentation 30-Apr-19 2:00pm GMT
finance.yahoo.com - May 1 at 8:03 AM
Meridian Bio takes out GenePOC for up to $120MMeridian Bio takes out GenePOC for up to $120M
seekingalpha.com - April 30 at 7:05 PM
Meridian Bioscience Q2 top line down 11%; suspends quarterly dividendMeridian Bioscience Q2 top line down 11%; suspends quarterly dividend
seekingalpha.com - April 30 at 7:05 PM
Meridian Bioscience Announces Agreement to Acquire Business of GenePOC; Adds State-of-the-Art Molecular Diagnostics PlatformMeridian Bioscience Announces Agreement to Acquire Business of GenePOC; Adds State-of-the-Art Molecular Diagnostics Platform
finance.yahoo.com - April 30 at 7:05 PM
Meridian Bioscience (VIVO) Q2 Earnings and Revenues Top EstimatesMeridian Bioscience (VIVO) Q2 Earnings and Revenues Top Estimates
finance.yahoo.com - April 30 at 7:05 PM
Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending AcquisitionMeridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending Acquisition
finance.yahoo.com - April 30 at 7:05 PM
Cincinnati public company could pay $120M for Canadian firmCincinnati public company could pay $120M for Canadian firm
finance.yahoo.com - April 30 at 7:05 PM
Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - April 23 at 6:45 PM
A Look At The Intrinsic Value Of Meridian Bioscience, Inc. (NASDAQ:VIVO)A Look At The Intrinsic Value Of Meridian Bioscience, Inc. (NASDAQ:VIVO)
finance.yahoo.com - April 19 at 7:19 PM
Meridian Launches a New Inhibitor Tolerant qPCR Reagent to Significantly Simplify Molecular Diagnostic Workflows From Crude SamplesMeridian Launches a New Inhibitor Tolerant qPCR Reagent to Significantly Simplify Molecular Diagnostic Workflows From Crude Samples
finance.yahoo.com - April 18 at 7:54 PM
Meridian Bioscience to Hold Second Quarter 2019 Financial Results Conference Call on April 30, 2019Meridian Bioscience to Hold Second Quarter 2019 Financial Results Conference Call on April 30, 2019
finance.yahoo.com - April 10 at 9:05 PM
Meridian Bioscience sees ~$50M in Q4 revenueMeridian Bioscience sees ~$50M in Q4 revenue
seekingalpha.com - April 2 at 4:56 PM
Meridian Bioscience Announces Preliminary Second Quarter 2019 Revenue Results; Updates Fiscal 2019 GuidanceMeridian Bioscience Announces Preliminary Second Quarter 2019 Revenue Results; Updates Fiscal 2019 Guidance
finance.yahoo.com - April 2 at 8:02 AM
Why Meridian Bioscience, Inc.’s (NASDAQ:VIVO) Cash Is A Factor You Need To ConsiderWhy Meridian Bioscience, Inc.’s (NASDAQ:VIVO) Cash Is A Factor You Need To Consider
finance.yahoo.com - March 27 at 8:05 PM
Meridian Bioscience Inc. Estimate MomentumMeridian Bioscience Inc. Estimate Momentum
www.nasdaq.com - March 18 at 8:14 PM
Meridian Launches New Range of Lyo-Ready PCR MixesMeridian Launches New Range of Lyo-Ready PCR Mixes
finance.yahoo.com - February 7 at 8:02 AM
Medical Products Industry Outlook: Plenty of Upside LeftMedical Products Industry Outlook: Plenty of Upside Left
finance.yahoo.com - January 29 at 6:29 PM
Meridian Bioscience (VIVO) Q1 2019 Earnings Conference Call TranscriptMeridian Bioscience (VIVO) Q1 2019 Earnings Conference Call Transcript
www.fool.com - January 25 at 11:45 PM
Edited Transcript of VIVO earnings conference call or presentation 24-Jan-19 2:00pm GMTEdited Transcript of VIVO earnings conference call or presentation 24-Jan-19 2:00pm GMT
finance.yahoo.com - January 25 at 8:02 AM
Meridian Bioscience, Inc. (VIVO) CEO Jack Kenny on Q1 2019 Results - Earnings Call TranscriptMeridian Bioscience, Inc. (VIVO) CEO Jack Kenny on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - January 24 at 6:48 PM
Meridian Bioscience (VIVO) Tops Q1 Earnings EstimatesMeridian Bioscience (VIVO) Tops Q1 Earnings Estimates
finance.yahoo.com - January 24 at 6:48 PM
Meridian Bioscience fiscal Q1 beats EPS consensusMeridian Bioscience fiscal Q1 beats EPS consensus
seekingalpha.com - January 24 at 8:01 AM
Meridian Bioscience Reports First Quarter 2019 Operating Results, Declares Regular First Quarter Cash Dividend, and Provides Updated Fiscal 2019 GuidanceMeridian Bioscience Reports First Quarter 2019 Operating Results, Declares Regular First Quarter Cash Dividend, and Provides Updated Fiscal 2019 Guidance
finance.yahoo.com - January 24 at 8:01 AM
Meridian Bioscience: Fiscal 1Q Earnings SnapshotMeridian Bioscience: Fiscal 1Q Earnings Snapshot
finance.yahoo.com - January 24 at 8:01 AM
A Spotlight On Meridian Bioscience, Inc.’s (NASDAQ:VIVO) FundamentalsA Spotlight On Meridian Bioscience, Inc.’s (NASDAQ:VIVO) Fundamentals
finance.yahoo.com - January 23 at 6:38 PM
Meridian Bioscience Announces Preliminary First Quarter 2019 Revenue; First Quarter 2019 FinancialMeridian Bioscience Announces Preliminary First Quarter 2019 Revenue; First Quarter 2019 Financial
www.nasdaq.com - January 7 at 6:37 PM
Meridian Bioscience -1.7% on preliminary Q1 revenuesMeridian Bioscience -1.7% on preliminary Q1 revenues
seekingalpha.com - January 7 at 6:37 PM
Meridian Bioscience Announces Preliminary First Quarter 2019 Revenue; First Quarter 2019 Financial Results Conference Call to be Held on January 24, 2019Meridian Bioscience Announces Preliminary First Quarter 2019 Revenue; First Quarter 2019 Financial Results Conference Call to be Held on January 24, 2019
finance.yahoo.com - January 7 at 6:37 PM
Meridian Bioscience (VIVO) Reports FDA Clearance for New Neonatal Saliva CMV TestMeridian Bioscience (VIVO) Reports FDA Clearance for New Neonatal Saliva CMV Test
www.streetinsider.com - December 7 at 8:05 AM
Meridian Gets FDA Clearance for New Neonatal Saliva CMV TestMeridian Gets FDA Clearance for New Neonatal Saliva CMV Test
finance.yahoo.com - December 6 at 8:06 AM
FDA Nod For First Test To Detect Herpes Virus In NewbornsFDA Nod For First Test To Detect Herpes Virus In Newborns
www.nasdaq.com - December 4 at 5:49 PM
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Featured Article: Bond

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel